These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28876451)

  • 1. Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.
    Ren J; Liao X; Vieson MD; Chen M; Scott R; Kazmierczak J; Luo XM; Reilly CM
    Clin Exp Immunol; 2018 Jan; 191(1):19-31. PubMed ID: 28876451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Histone Deacetylase 6 Inhibition Normalizes B Cell Activation and Germinal Center Formation in a Model of Systemic Lupus Erythematosus.
    Ren J; Catalina MD; Eden K; Liao X; Read KA; Luo X; McMillan RP; Hulver MW; Jarpe M; Bachali P; Grammer AC; Lipsky PE; Reilly CM
    Front Immunol; 2019; 10():2512. PubMed ID: 31708928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a selective histone deacetylase 6 inhibitor decreases lupus nephritis in NZB/W mice.
    Vieson MD; Gojmerac AM; Khan D; Dai R; van Duzer JH; Mazitschek R; Caudell DL; Liao X; Luo XM; Reilly CM
    Histol Histopathol; 2017 Dec; 32(12):1317-1332. PubMed ID: 28245046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
    Davison LM; Jørgensen TN
    Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
    Pau E; Chang NH; Loh C; Lajoie G; Wither JE
    Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.
    Bethunaickan R; Sahu R; Liu Z; Tang YT; Huang W; Edegbe O; Tao H; Ramanujam M; Madaio MP; Davidson A
    Arthritis Rheum; 2012 Oct; 64(10):3399-408. PubMed ID: 22674120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice.
    Regna NL; Vieson MD; Luo XM; Chafin CB; Puthiyaveetil AG; Hammond SE; Caudell DL; Jarpe MB; Reilly CM
    Clin Immunol; 2016 Jan; 162():58-73. PubMed ID: 26604012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice.
    Liu Z; Bethunaickan R; Huang W; Ramanujam M; Madaio MP; Davidson A
    J Immunol; 2011 Aug; 187(3):1506-13. PubMed ID: 21705616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC6 Deletion Decreases Pristane-induced Inflammation.
    Xu D; Luo XM; Reilly CM
    Immunohorizons; 2024 Sep; 8(9):668-678. PubMed ID: 39259207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus.
    Choi EW; Song JW; Ha N; Choi YI; Kim S
    Sci Rep; 2018 Nov; 8(1):17297. PubMed ID: 30470828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase 6 inhibitor enhances resistance to Mycobacterium tuberculosis infection through innate and adaptive immunity in mice.
    Wang X; Tang X; Zhou Z; Huang Q
    Pathog Dis; 2018 Aug; 76(6):. PubMed ID: 30085165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC expression and activity is upregulated in diseased lupus-prone mice.
    Regna NL; Vieson MD; Gojmerac AM; Luo XM; Caudell DL; Reilly CM
    Int Immunopharmacol; 2015 Dec; 29(2):494-503. PubMed ID: 26471208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
    Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
    J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
    Moon JS; Mun CH; Kim JH; Cho JY; Park SD; Park TY; Shin JS; Ho CC; Park YB; Ghosh S; Bothwell ALM; Lee SW; Lee SK
    Kidney Int; 2018 May; 93(5):1118-1130. PubMed ID: 29409726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
    J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.